SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607900. A total of 7 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,843,974 | +52.3% | 196,700 | +43.9% | 0.08% | +60.0% |
| Q2 2023 | $15,654,884 | -17.8% | 136,700 | -1.0% | 0.05% | -27.5% |
| Q1 2023 | $19,034,323 | -63.6% | 138,100 | -65.8% | 0.07% | -43.4% |
| Q4 2022 | $52,285,530 | +59.7% | 403,500 | +36.2% | 0.12% | +90.6% |
| Q3 2022 | $32,742,000 | +58.0% | 296,200 | +7.1% | 0.06% | +100.0% |
| Q2 2022 | $20,726,000 | -43.4% | 276,500 | -41.1% | 0.03% | -11.1% |
| Q1 2022 | $36,646,000 | +50.9% | 469,100 | +73.9% | 0.04% | +80.0% |
| Q4 2021 | $24,286,000 | +111.8% | 269,700 | +117.5% | 0.02% | +66.7% |
| Q3 2021 | $11,468,000 | +1.9% | 124,000 | -14.4% | 0.01% | -14.3% |
| Q2 2021 | $11,257,000 | -16.8% | 144,800 | -20.2% | 0.01% | -30.0% |
| Q1 2021 | $13,527,000 | -69.5% | 181,500 | -30.3% | 0.02% | -74.0% |
| Q4 2020 | $44,413,000 | +39.6% | 260,500 | +15.0% | 0.08% | -23.0% |
| Q3 2020 | $31,807,000 | -14.6% | 226,500 | -2.5% | 0.10% | -41.9% |
| Q2 2020 | $37,263,000 | +85.8% | 232,400 | +13.4% | 0.17% | +5.5% |
| Q1 2020 | $20,053,000 | -58.1% | 205,000 | -44.8% | 0.16% | -50.0% |
| Q4 2019 | $47,887,000 | +113.6% | 371,100 | +24.7% | 0.33% | +80.1% |
| Q3 2019 | $22,415,000 | -42.6% | 297,600 | +15.8% | 0.18% | -48.9% |
| Q2 2019 | $39,066,000 | +17.9% | 257,100 | -7.5% | 0.35% | -4.1% |
| Q1 2019 | $33,123,000 | +58.4% | 277,900 | +45.0% | 0.37% | +103.9% |
| Q4 2018 | $20,909,000 | -56.0% | 191,600 | -34.8% | 0.18% | -51.7% |
| Q3 2018 | $47,484,000 | +18.6% | 294,000 | -2.9% | 0.38% | +9.6% |
| Q2 2018 | $40,024,000 | +83.0% | 302,800 | +2.6% | 0.34% | +55.5% |
| Q1 2018 | $21,871,000 | +59.5% | 295,200 | +19.8% | 0.22% | +129.2% |
| Q4 2017 | $13,715,000 | -9.6% | 246,500 | -26.3% | 0.10% | -30.4% |
| Q3 2017 | $15,173,000 | +103.6% | 334,500 | +51.3% | 0.14% | +79.2% |
| Q2 2017 | $7,453,000 | +3.4% | 221,100 | -9.2% | 0.08% | -8.3% |
| Q1 2017 | $7,208,000 | -64.5% | 243,500 | -67.1% | 0.08% | -57.4% |
| Q4 2016 | $20,328,000 | -69.7% | 741,100 | -32.1% | 0.20% | -72.9% |
| Q3 2016 | $67,072,000 | +138.2% | 1,092,200 | -26.0% | 0.73% | +118.6% |
| Q2 2016 | $28,157,000 | +215.7% | 1,476,500 | +223.2% | 0.33% | +164.3% |
| Q1 2016 | $8,919,000 | -46.2% | 456,900 | +6.3% | 0.13% | -35.7% |
| Q4 2015 | $16,582,000 | +58.9% | 429,800 | +32.3% | 0.20% | +36.1% |
| Q3 2015 | $10,433,000 | +4.8% | 324,900 | -0.7% | 0.14% | +3.6% |
| Q2 2015 | $9,954,000 | +201.7% | 327,100 | +31.7% | 0.14% | +167.3% |
| Q1 2015 | $3,299,000 | -53.3% | 248,400 | -49.2% | 0.05% | -51.4% |
| Q4 2014 | $7,069,000 | -24.2% | 488,500 | +10.5% | 0.11% | -25.7% |
| Q3 2014 | $9,324,000 | +1.6% | 441,900 | +43.4% | 0.14% | +2.1% |
| Q2 2014 | $9,178,000 | -7.3% | 308,100 | -25.2% | 0.14% | -15.1% |
| Q1 2014 | $9,896,000 | +15.2% | 411,800 | -2.3% | 0.17% | +27.7% |
| Q4 2013 | $8,590,000 | -43.3% | 421,700 | +31.5% | 0.13% | -55.2% |
| Q3 2013 | $15,147,000 | +187.4% | 320,700 | +131.6% | 0.29% | +123.1% |
| Q2 2013 | $5,270,000 | – | 138,500 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 124,000 | $11,468,000 | 0.01% |
| JPMORGAN CHASE & CO | 200,000 | $18,496,000 | 0.00% |
| SIMPLEX TRADING, LLC | 32,500 | $2,543,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |